BETA

Activities of Véronique TRILLET-LENOIR related to 2020/0262(COD)

Plenary speeches (1)

Protection of workers from the risks relating to exposure to carcinogens, mutagens and reprotoxins at work (debate)
2022/02/17
Dossiers: 2020/0262(COD)

Shadow reports (1)

REPORT on the proposal for a directive of the European Parliament and of the Council amending Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work
2021/04/07
Committee: EMPL
Dossiers: 2020/0262(COD)
Documents: PDF(331 KB) DOC(140 KB)
Authors: [{'name': 'Stefania ZAMBELLI', 'mepid': 197586}]

Amendments (63)

Amendment 13 #
Draft legislative resolution
Citation 3 a (new)
- having regard to the Charter of Fundamental Rights of the European Union, and in particular Article 2 (the right to life) and Article 31(the right to fair and just working conditions),
2021/02/05
Committee: EMPL
Amendment 14 #
Proposal for a directive
Recital -1 (new)
(-1) A high level of human health protection should be ensured in the definition and implementation of all Union policies and activities.
2021/02/05
Committee: EMPL
Amendment 16 #
Proposal for a directive
Recital 1 a (new)
(1a) In the workplace, workers and other persons are often exposed to a cocktail of substances, which can increase health risks, cause adverse effects on their reproductive systems and cause impaired fertility or infertility, and have a negative impact on foetal development and lactation. Substances which are toxic to reproduction are of very high concern and the organisation of workplace prevention should apply the same approach as for carcinogens and mutagens. As not all reprotoxic substances are threshold substances, it is of utmost importance to enlarge the scope of Directive 2004/37/EC to reprotoxic substances in order to bring it in line with Regulation (EC) No 1907/2006 of the European Parliament and of the Council1a. This is necessary to better protect workers and their children and to ensure the safe participation of all workers in the workplace, in particular female workers who are pregnant or breastfeeding. In Regulation (EC) No 1907/2006, half of the 211 substances identified as substances of very high concern are reprotoxic substances. As is the case in some Member States, the organisation of workplace prevention should therefore apply the same approach to carcinogens, mutagens and reprotoxic substances, thus ensuring legal coherence and a level playing field across Member States.. ____________________ 1aRegulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).
2021/02/05
Committee: EMPL
Amendment 17 #
Proposal for a directive
Recital 1 a (new)
(1a) This Directive clearly shows the added value of the Union and the need to adopt legislation at the Union level. In addition to setting similar minimum level of protection across the Union, this Directive also improves clarity and enforcement, and contributes to a better level playing field for the economic actors in the sectors using the substances covered.
2021/02/05
Committee: EMPL
Amendment 18 #
Proposal for a directive
Recital 1 b (new)
(1b) It is important to protect sexual and reproductive health and to apply a gender perspective to health and safety at work. Workers can be more exposed and more vulnerable to different types of substances depending on their gender. Women are for example over-represented amongst the oncology nurses community potentially exposed to hazardous medicinal products.
2021/02/05
Committee: EMPL
Amendment 19 #
Proposal for a directive
Recital 2
(2) Principle 10 of the European Pillar of Social Rights46 , jointly proclaimed by the European Parliament, the Council and the Commission at the Social Summit for Fair Jobs and Growth on 17 November 2017, provides workers’ right to a high level of protection of their health and safety at work, which includes the protection from the exposure to carcinogens and mutagen, mutagens and reprotoxic substances at the workplace. __________________ 46European Pillar of Social Rights, November 2017, available at : https://ec.europa.eu/commission/sites/beta- political/files/social-summit-european- pillar-social-rights-booklet_en.pdf
2021/02/05
Committee: EMPL
Amendment 22 #
Proposal for a directive
Recital 2 a (new)
(2a) Europe’s Beating Cancer Plan aims to reduce the cancer burden for patients, their families and health systems. Cancer is the first cause of work-related death in the Union: 52 % of annual occupational deaths are currently attributed to work-related cancers. Exposure at work accounts for 3,5-4 % cases of cancer and is responsible for approximatively 120 .000 cancers diagnosed and 80 000 deaths every year.
2021/02/05
Committee: EMPL
Amendment 23 #
Proposal for a directive
Recital 2 b (new)
(2b) Tackling exposures to dangerous substances at the workplace is particularly relevant to foster prevention and address health inequalities, as some categories of workers among the most vulnerable can be overexposed. Some workers, such as mobile workers, can additionally face difficulties to access healthcare services.
2021/02/05
Committee: EMPL
Amendment 25 #
Proposal for a directive
Recital 3
(3) Binding occupational exposure limit values are important component of the general arrangements for the protection of workers established by Directive 2004/37/EC and must not be exceeded. Limit values and other directly related provisions should be established for all those carcinogens or, mutagens and reprotoxic substances for which the available information, including scientific and technical data, make this possible.
2021/02/05
Committee: EMPL
Amendment 27 #
Proposal for a directive
Recital 4
(4) Compliance with binding occupational exposure limit values is without prejudice to other employers’ obligations pursuant to Directive 2004/37/EC, such as the reduction of the use of carcinogens and mutagen, mutagens and reprotoxic substances at the workplace, the prevention or reduction of workers’ exposure to carcinogens or mutagen, mutagens or reprotoxic substances and the measures which should be implemented to that effect. Those measures should include, as far as it is technically possible, the replacement of the carcinogen or, mutagen and reprotoxic substance by a substance, mixture or process which is not dangerous or is less dangerous to workers’ health, the use of a closed system or other measures aiming to reduce the level of workers’ exposure.
2021/02/05
Committee: EMPL
Amendment 28 #
Proposal for a directive
Recital 4 a (new)
(4a) Commission Recommendation 2003/670/EC1a recommends that Member States introduce into their national laws, regulations or administrative provisions concerning scientifically recognised occupational diseases liable for compensation and subject to preventive measures. Member States should guarantee, in their national laws, that every worker has the right to compensation in respect of occupational diseases if he or she is suffering from an ailment which can be proved to be occupational in origin and nature. ________________ 1a. Commission Recommendation 2003/670/EC of 19 September 2003 concerning the European schedule of occupational diseases (OJ L 238, 25.9.2003, p. 28).
2021/02/05
Committee: EMPL
Amendment 30 #
Proposal for a directive
Recital 4 b (new)
(4b) However, the reporting and recognition of occupational cancers as occupational diseases are uneven, due. in particular, to a long latency between the exposure to dangerous substances and the diagnosis of the disease, the multifactorial nature of cancer but also to complex procedures to undertake in order to have the illness officially recognised as work- related and to obtain compensation. Data from work-related health problems are often lacking, not reliable or insufficient. Further efforts are therefore needed to improve reporting, prevention, diagnosis, early recognition and compensation of occupational diseases, as well as better medical monitoring throughout life with robust diseases and exposures registries.
2021/02/05
Committee: EMPL
Amendment 38 #
Proposal for a directive
Recital 5
(5) This Directive strengthens the protection of workers’ health and safety at their workplace. New limit values should be set out in Directive 2004/37/EC in the light ofusing a risk-based methodology. All available information should be considered, including new scientific and technical data and should also be based on, a thorough assessment of the socioeconomic impact and the availability of exposure measurement protocols and techniques at the workplace. That information should, if possible, include data on residual risks to the health of workers, opinions of the Committee for Risk Assessment (RAC) of the European Chemicals Agency (ECHA), as well as opinions of the Advisory Committee on Safety and Health at Work (ACSH). Information related to residual risk, made publicly available at Union level, is valuable for any future work to limit risks from occupational exposure to carcinogens and mutagens.
2021/02/05
Committee: EMPL
Amendment 39 #
Proposal for a directive
Recital 5
(5) This Directive strengthens the protection of workers’ health and safety at their workplace. New limit values should be set out in Directive 2004/37/EC in the light of available information, including new scientific and technical data and should also be based on a thorough assessment of the socioeconomic impact and availability of exposure measurement protocols and techniques at the workplace. That information should, if possible, include data on residual risks to the health of workers, opinions of the Committee for Risk Assessment (RAC) of the European Chemicals Agency (ECHA), as well as opinions of the Advisory Committee on Safety and Health at Work (ACSH). Information related to residual risk, made publicly available at Union level, is valuable for any future work to limit risks from occupational exposure to carcinogens and mutagen, mutagens and reprotoxic substances.
2021/02/05
Committee: EMPL
Amendment 40 #
Proposal for a directive
Recital 6
(6) In accordance with the recommendations of the RAC and the ACSH, where possible, limit values for the inhalation route of exposure are established in relation to a reference period of eight hours time-weighted average (long-term exposure limit values) and, for certain carcinogens or, mutagens and reprotoxic substances to a shorter reference period, in general fifteen minutes time-weighted average (short-term exposure limit values), in order to limit, to the extent possible, the effects arising from short-term exposure.
2021/02/05
Committee: EMPL
Amendment 41 #
Proposal for a directive
Recital 7
(7) It is also necessary to consider other absorption pathways other than inhalation of all carcinogens and mutagen, mutagens and reprotoxic substances, including the possibility of uptake through the skin, in order to ensure the best possible level of protection.
2021/02/05
Committee: EMPL
Amendment 42 #
Proposal for a directive
Recital 7 a (new)
(7a) In the workplace, workers are often exposed to a cocktail of hazardous substances, which can increase risks and cause adverse health effects. In the case of exposure to a combination of substances acting by the same mode of action or at the same target cell or tissue, it is necessary to adapt the implementation of their possible limit values to take into account the combined effects.
2021/02/05
Committee: EMPL
Amendment 43 #
Proposal for a directive
Recital 9
(9) Acrylonitrile meets the criteria for classification as carcinogenic (category 1B) in accordance with Regulation (EC) No 1272/2008 of the European Parliament and the Council47 and is therefore carcinogen within the meaning of Directive 2004/37/EC. It is possible, on the basis of the available information, including scientific and technical data, to set a long- and short-term limit value for that carcinogen. Acrylonitrile can also be absorbed through the skin. Acrylonitrile is acutely toxic and causes neurotoxicity, local irritation of skin, eyes and respiratory tract, and skin sensitisation. It is therefore appropriate to establish a limit value for acrylonitrile under the scope of Directive 2004/37/EC and to assign a skin notation to it. The ACSH, based on the RAC opinion, agreed on the usefulness of the biomonitoring for acrylonitrile. This should be considered when developing guidance on the practical use of biomonitoring. __________________ 47Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures. Available at: https://eur-lex.europa.eu/legal- content/EN/ALL/?uri=CELEX%3A32008 R1272.
2021/02/05
Committee: EMPL
Amendment 44 #
Proposal for a directive
Recital 10
(10) With regard to acrylonitrile, a limit value of 1 mg/m³ (0.45 ppm) and a short- term limit value of 4 mg/m³ (1.8 ppm) may be difficult to be complied with in the short term. A transitional period of four years after entry into force of this Directive should be introduced from which these Occupational Exposure Limit (OEL) values shall apply. Exposure should be reduced as far as technically possible below these limit values.
2021/02/05
Committee: EMPL
Amendment 45 #
Proposal for a directive
Recital 11
(11) Nickel compounds meet the criteria for classification as carcinogenic (category 1A) in accordance with Regulation (EC) No 1272/2008 and are therefore carcinogens within the meaning of Directive 2004/37/EC. It is possible, on the basis of the available information, including scientific and technical data, to set limit values for that group of carcinogens. According to the RAC, the available information on the mechanisms of genotoxicity and cancer support a mode-of-action based threshold for carcinogenic effects. For that reason, the RAC proposed an occupational exposure limit of 0.005 mg/m³ for the respirable fraction and 0.03 mg/m³ for the inhalable fraction under which no significant residual cancer risk is expected for workers. Exposure to nickel compounds at workplaces may also result in dermal sensitisation and sensitisation of the respiratory tract. It is therefore appropriate to establish two limit values for both the inhalable and respirable fractions of the nickel compounds under the scope of Directive 2004/37/EC and to assign a notation for dermal and respiratory sensitisation. Based on the consensus between the social partners within the ACSH, limit values of 0.01 mg/m³ for the respirable fraction and 0.05 mg/m³ for the inhalable fraction are introduced. Exposure should be reduced as far as technically possible below these limit values and, when possible, below the limit values proposed by the RAC.
2021/02/05
Committee: EMPL
Amendment 50 #
Proposal for a directive
Recital 13
(13) Benzene meets the criteria for classification as carcinogenic (category 1A) in accordance with Regulation (EC) No 1272/2008 and is therefore carcinogen within the meaning of Directive 2004/37/EC. According to the RAC, a mode-of-action-based threshold for chromosomal damage in workers can be used to establish an occupational exposure limit for carcinogenicity which is considered to have no significant residual cancer risk and to avoid other adverse effects. For this reason, the RAC proposed an Occupational Exposure limit of 0.05 ppm (0.16mg/m³). Benzene can also be absorbed through the skin. The limit value set out in Annex III to Directive 2004/37/EC for benzene should be revised in the light of more recent scientific data and it is appropriate to keep the skin notation. The ACSH, based on the RAC opinion, agreed on the usefulness of the biomonitoring for benzene. This should be considered when developing guidance on the practical use of biomonitoring. Based on a consensus between the social partners in the ACSH, a revised limit value of 0.2 ppm (0.66 mg/m³) is introduced. Exposure should be reduced as far as technically possible below this limit value and, when possible, below the limit value proposed by the RAC.
2021/02/05
Committee: EMPL
Amendment 52 #
Proposal for a directive
Recital 13
(13) Benzene meets the criteria for classification as carcinogenic (category 1A) in accordance with Regulation (EC) No 1272/2008 and is therefore carcinogen within the meaning of Directive 2004/37/EC. Benzene can also be absorbed through the skin. The limit value set out in Annex III to Directive 2004/37/EC for benzene should be revised in the light of more recent scientific data no later than 1 January 2030 in accordance with the ACSH opinion and it is appropriate to keep the skin notation. The ACSH, based on the RAC opinion, also agreed on the usefulness of the biomonitoring for benzene. This should be considered when developing guidance on the practical use of biomonitoring.
2021/02/05
Committee: EMPL
Amendment 57 #
Proposal for a directive
Recital 14 b (new)
(14b) Hazardous Medicinal Products can cause adverse health effects, such as certain types of cancer and reproductive disorders, in workers who are exposed to them in the course of work involving their preparation, administration, or disposal. Hazardous Medicinal Products affect workers who handle them directly or indirectly. Such workers include healthcare workers using cytostatic or cytotoxic drugs to treat cancer patients in hospitals or at home and workers who carry out activities relating to the cleaning, transport, laundry, or the waste disposal of hazardous drugs or of material contaminated by such drugs. It is therefore important to protect all workers by including relevant pharmacotherapeutic groups of Hazardous Medicinal Products in Annex I to Directive 2004/37/EC. The reduction and replacement requirements laid down in Article 4 of that Directive do not apply to Hazardous Medicinal Products because they are essential to treat patients. The other provisions of that Directive, in particular Articles 5 to 18a thereof, as amended by this Regulation, apply to workers who are exposed to Hazardous Medicinal Products.
2021/02/05
Committee: EMPL
Amendment 60 #
Proposal for a directive
Recital 16
(16) The limit values established in this Directive are to be kept under regularpermanent scrutiny and regular review to ensure consistency with Regulation (EC) No 1907/200649. __________________ 49Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals. Available at: https://eur-lex.europa.eu/legal- content/EN/ALL/?uri=CELEX%3A32006 R1907.
2021/02/05
Committee: EMPL
Amendment 61 #
Proposal for a directive
Recital 17
(17) Since the objective of this Directive, namely to protect workers against risks to their health and safety, including the prevention of such risks, arising or likely to arise from exposure to carcinogens or mutagen, mutagens or reprotoxic substances at work, cannot be sufficiently achieved by the Member States, but can rather, by reason of its scale and effects, be better achieved at Union level, the Union may adopt measures, in accordance with the principle of subsidiarity as set out in Article 5 of the Treaty on European Union. In accordance with the principle of proportionality, as set out in that Article, this Directive does not go beyond what is necessary in order to achieve that objective.
2021/02/05
Committee: EMPL
Amendment 62 #
Proposal for a directive
Recital 17 a (new)
(17a) It is important to ensure operational feasibility and compliance by SMEs and to take all necessary actions to ensure the safety and health of workers are protected no matter the size of the enterprise. The European Agency for Health and Safety at Work has an important role to play in this regard, in particular to help SMEs assess the risks for their workforce and implement adequate protective measures.
2021/02/05
Committee: EMPL
Amendment 64 #
Proposal for a directive
Article 1 – point -1 (new)
Directive 2004/37/EC
Title
(-1) The title of Directive 2004/37/EC is replaced by the following: "DIRECTIVE 2004/37/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 29 April 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagen, mutagens or reprotoxic substances at work (Sixth individual Directive within the meaning of Article 16(1) of Council Directive 89/391/EEC)"
2021/02/05
Committee: EMPL
Amendment 65 #
Proposal for a directive
Article 1 – point -1 a (new)
Directive 2004/37/EC
Article 1 – paragraph 1 – subparagraph 1
(-1a) In Article 1(1), the first paragraph is replaced by the following: “1. This Directive has as its aim the protection of workers against risks to their health and safety, including the prevention of such risks, arising or likely to arise from exposure to carcinogens or, mutagens or reprotoxic substances at work.
2021/02/05
Committee: EMPL
Amendment 66 #
Proposal for a directive
Article 1 – point -1 b (new)
Directive 2004/37/EC
Article 2 – point b a (new)
(-1b) In Article 2, the following point is inserted: "(ba) 'reprotoxic substance' means: a substance or mixture which meets the criteria for being classified as toxic to reproduction category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008;"
2021/02/05
Committee: EMPL
Amendment 67 #
Proposal for a directive
Article 1 – point -1 c (new)
Directive 2004/37/EC
Article 2 – point c (new)
(-1c) In Article 2, point (c) is replaced by the following: “(c) 'limit value' means, unless otherwise specified, the limit of the time- weighted average of the concentration for a 'carcinogen or mutagen’, mutagen or reprotoxic substance' in the air within the breathing zone of a worker in relation to a specified reference period as set out in Annex III to this Directive.
2021/02/05
Committee: EMPL
Amendment 68 #
Proposal for a directive
Article 1 – point -1 d (new)
Directive 2004/37/EC
Article 2 – point c a (new)
(-1d) In Article 2, the following point is added: "(ca) 'risk-based limit value' means: a limit value set at an exposure level corresponding to a risk of developing an adverse health effect (e.g. cancer) in the range between an upper and a lower risk level, which is to be set in accordance with the procedure laid down in Article 153(2) of the Treaty on the Functioning of the European Union (TFEU)."
2021/02/05
Committee: EMPL
Amendment 69 #
Proposal for a directive
Article 1 – point -1 e (new)
Directive 2004/37/EC
Article 3 – paragraph 1
(-1e) In Article 3, paragraph 1 is replaced by the following: "1. This Directive shall apply to activities in which workers are or are likely to be exposed to carcinogens or, mutagens or reprotoxic substances as a result of their work.
2021/02/05
Committee: EMPL
Amendment 71 #
Proposal for a directive
Article 1 – point -1 g (new)
Directive 2004/37/EC
Article 3 – paragraph 2 – subparagraph 1
(-1g) In Article 3(2), the first subparagraph is replaced by the following: "In the case of any activity likely to involve a risk of exposure to carcinogens or mutagen, mutagens or reprotoxic substances, the nature, degree and duration of workers' exposure shall be determined in order to make it possible to assess any risk to the workers' health or safety and to lay down the measures to be taken.
2021/02/05
Committee: EMPL
Amendment 72 #
Proposal for a directive
Article 1 – point -1 h (new)
Directive 2004/37/EC
Article 3 – paragraph 2 – subparagraph 2
(-1h) In Article 3(2), the second subparagraph is replaced by the following: “The assessment shall be renewed regularly and in any event when any change occurs in the conditions which may affect workers' exposure to carcinogens or, mutagens. or reprotoxic substances.”
2021/02/05
Committee: EMPL
Amendment 73 #
Proposal for a directive
Article 1 – point -1 i (new)
Directive 2004/37/EC
Article 3 – paragraph 4
(-1i) In Article 3, paragraph 4 is replaced by the following: "4. When the risk assessment is carried out, employers shall give particular attention to any effects concerning the health or safety of workers at particular risk and shall, inter alia, take account of the desirability of not employing such workers in areas where they may come into contact with carcinogens or, mutagens. or reprotoxic substances.”
2021/02/05
Committee: EMPL
Amendment 74 #
Proposal for a directive
Article 1 – point -1 j (new)
Directive 2004/37/EC
Article 4 – paragraph 1
1. The employer shall reduce the use of a carcinogen or mutag(-1j) In Article 4, paragraph 1 is replaced by the following: "1. Where a carcinogen, mutagen or reprotoxic substance is present at the workplace of work, the employer shall reduce its use, in particular by replacing it, in so far as is technically possible, by a substance, mixture or process which, under its conditions of use, is not dangerous or is less dangerous to workers' health or safety, as the case may be. This paragraph shall not apply to the use of hazardous medicinal products set out in Annex I.”
2021/02/05
Committee: EMPL
Amendment 75 #
Proposal for a directive
Article 1 – point -1 k (new)
Directive 2004/37/EC
Article 5 – paragraph 2
(-1k) In Article 5, paragraph 2 is replaced by the following: “2. Where it is not technically possible to replace the carcinogen or, mutagen or reprotoxic substance by a substance, mixture or process which, under its conditions of use, is not dangerous or is less dangerous to health or safety, the employer shall ensure that the carcinogen or, mutagen or reprotoxic substance is, in so far as is technically possible, manufactured and used in a closed system.
2021/02/05
Committee: EMPL
Amendment 76 #
Proposal for a directive
Article 1 – point -1 l (new)
Directive 2004/37/EC
Article 5 – paragraph 4
(-1l) In Article 5, paragraph 4 is replaced by the following: “4. Exposure shall not exceed the limit value of a carcinogen, mutagen or reprotoxic substance as set out in Annex III.
2021/02/05
Committee: EMPL
Amendment 77 #
Proposal for a directive
Article 1 – point -1 m (new)
Directive 2004/37/EC
Article 5 – paragraph 4
4. Exposure shall not exceed the limit value of a carcinogen as set out in Annex III.(-1m) In Article 5, paragraph 4 is replaced by the following: “4. Exposure shall not exceed the limit value of a substance as set out in Annex III. In the case of exposure to a combination of substances acting by the same mode of action or at the same target cell or tissue, the implementation of their eventual limit values shall be adapted to take into account the combined effects.”
2021/02/05
Committee: EMPL
Amendment 78 #
Proposal for a directive
Article 2 – point -1 n (new)
Directive 2004/37/EC
Article 5 – paragraph 5 – introductory part
-1n. In Article 5(5), the introductory part is replaced by the following: “5. Wherever a carcinogen or, mutagen or reprotoxic substance is used, the employer shall apply all the following measures:
2021/02/05
Committee: EMPL
Amendment 79 #
Proposal for a directive
Article 1 – point -1 o (new)
Directive 2004/37/EC
Article 5 – paragraph 5 – point a
(-1o) In Article 5(5), point (a) is replaced by the following: “(a) limitation of the quantities of a carcinogen or, mutagen or reprotoxic substance at the place of work;
2021/02/05
Committee: EMPL
Amendment 80 #
Proposal for a directive
Article 1 – point -1 p (new)
Directive 2004/37/EC
Article 5 – paragraph 5 – point c
(-1p) In Article 5(5), point (c) is replaced by the following: "(c) design of work processes and engineering control measures so as to avoid or minimise the release of carcinogens or, mutagens or reprotoxic substances into the place of work;
2021/02/05
Committee: EMPL
Amendment 81 #
Proposal for a directive
Article 1 – point -1 q (new)
Directive 2004/37/EC
Article 5 – paragraph 5 – point d
(-1q) In Article 5(5), point (d) is replaced by the following: “(d) evacuation of carcinogens or, mutagens or reprotoxic substances at source, local extraction system or general ventilation, all such methods to be appropriate and compatible with the need to protect public health and the environment;
2021/02/05
Committee: EMPL
Amendment 82 #
Proposal for a directive
Article 1 – point -1 r (new)
Directive 2004/37/EC
Article 5 – paragraph 5 – point e
(-1r) In Article 5(5), point (e) is replaced by the following: “(e) use of existing appropriate procedures for the measurement of carcinogens or mutagen, mutagens or reprotoxic substances, in particular for the early detection of abnormal exposures resulting from an unforeseeable event or an accident;
2021/02/05
Committee: EMPL
Amendment 84 #
Proposal for a directive
Article 1 – point -1 t (new)
Directive 2004/37/EC
Article 5 – paragraph 5 – point j
(-1t) In Article 5(5), point (j) is replaced by the following: “(j) demarcation of risk areas and use of adequate warning and safety signs including 'no smoking' signs in areas where workers are exposed or likely to be exposed to carcinogens or mutagen, mutagens or reprotoxic substances;
2021/02/05
Committee: EMPL
Amendment 86 #
Proposal for a directive
Article 1 – point -1 v (new)
Directive 2004/37/EC
Article 6 – paragraph 1– point a
(-1v) In the first paragraph of Article 6, point (a) is replaced by the following: "(a) the activities and/or industrial processes carried out, including the reasons for which carcinogens or, mutagens or reprotoxic substances are used;
2021/02/05
Committee: EMPL
Amendment 87 #
Proposal for a directive
Article 1 – point -1 w (new)
Directive 2004/37/EC
Article 6 – paragraph 1 – point b
(-1w) In the first paragraph of Article 6, point (b) is replaced by the following: “(b) the quantities of substances or mixtures manufactured or used which contain carcinogens or mutagen, mutagens or reprotoxic substances; "
2021/02/05
Committee: EMPL
Amendment 88 #
Proposal for a directive
Article 1 – point -1 x (new)
Directive 2004/37/EC
Article 10 – paragraph 1 – introductory part
(-1x) In Article 10 (1), the introductory part is replaced by the following: “1. Employers shall be obliged, in the case of all activities for which there is a risk of contamination by carcinogens or mutagen, mutagens or reprotoxic substances, to take appropriate measures to ensure that:
2021/02/05
Committee: EMPL
Amendment 89 #
Proposal for a directive
Article 1 – point -1 y (new)
Directive 2004/37/EC
Article 10 – paragraph 1 – point a
(-1y) In Article 10(1), point (a) is replaced by the following: “(a) workers do not eat, drink or smoke in working areas where there is a risk of contamination by carcinogens or, mutagens; or reprotoxic substances;”
2021/02/05
Committee: EMPL
Amendment 92 #
Proposal for a directive
Article 1 – point -1 ab (new)
Directive 2004/37/EC
Article 11 – paragraph 2
(-1ab) In Article 11, paragraph 2 is replaced by the following: “2. Employers shall inform workers of installations and related containers containing carcinogens or, mutagens or reprotoxic substances, ensure that all containers, packages and installations containing carcinogens or mutagen, mutagens or reprotoxic substances are labelled clearly and legibly, and display clearly visible warning and hazard signs.
2021/02/05
Committee: EMPL
Amendment 93 #
Proposal for a directive
Article 1 – point -1 ac (new)
Directive 2004/37/EC
Article 14 – paragraph 3 – subparagraph 1
(-1ac) In Article 14(3), the first subparagraph is replaced by the following: “3. If a worker is found to be suffering from an abnormality which is suspected to be the result of exposure to carcinogens or mutagen, mutagens or reprotoxic substances, the doctor or authority responsible for the health surveillance of workers may require other workers who have been similarly exposed to undergo health surveillance.
2021/02/05
Committee: EMPL
Amendment 94 #
Proposal for a directive
Article 1 – point -1 ad (new)
Directive 2004/37/EC
Article 14 – paragraph 8 – subparagraph 1
All cases of canc(-1ad) In Article 14(8), the first subparagraph is replaced by the following: “All cases of cancer and reproductive disorder identified in accordance with national law or practice as resulting from occupational exposure to a carcinogen or, mutagen or reprotoxic substance shall be notified to the competent authority.
2021/02/05
Committee: EMPL
Amendment 95 #
Proposal for a directive
Article 1 – point -1 ae (new)
Directive 2004/37/EC
Article 14 – paragraph 8 – subparagraph 1
8. All cases of canc(-1ae) In Article 14(8), the first subparagraph is replaced by the following: “8. All cases of cancer and reproductive disorder identified in accordance with national laws and/or practice as resulting from occupational exposure to a carcinogen or, mutagen or reprotoxic substance shall be notified to the competent authority. The Member States shall include the information referred to in this paragraph in their implementation reports submitted to the Commission pursuant to Article 17a of Directive 89/391/EEC.”
2021/02/05
Committee: EMPL
Amendment 96 #
Proposal for a directive
Article 1 – point -1 af (new)
Directive 2004/37/EC
Article 15 – paragraph 2 a (new)
(-1af) In Article 15, the following paragraph is added: “2a. The Member States shall provide the Commission with the information referred to in Article 14(8) as part of the implementation reports submitted to the Commission pursuant to Article 17a of Directive 89/391/EEC.”
2021/02/05
Committee: EMPL
Amendment 97 #
Proposal for a directive
Article 1 – point -1 ag (new)
Directive 2004/37/EC
Article 16 – paragraph 1
1. T(-1ag) In Article 16, paragraph 1 is replaced by the following: "1. The European Parliament and the Council shall, in accordance with the procedure laid down in Article 1537(2) of the TreatyTFEU, set out limit values in Directives on the basis of the available information, including scientific and technical data, in respect of all those carcinogens or mutagen, mutagens or reprotoxic substances for which this is possible, and, where necessary, other directly related provisions.
2021/02/05
Committee: EMPL
Amendment 98 #
Proposal for a directive
Article 1 – point -1 ah (new)
Directive 2004/37/EC
Article 16 – paragraph 1
1. T(-1 ah) In Article 16, paragraph 1 is replaced by the following: "1. The European Parliament and the Council shall, in accordance with the procedure laid down in Article 1537(2) of the Treaty, set out risk-based limit values in Directives on the basis of the available information, including scientific and technical data, in respect of all those carcinogens or, mutagens for which this is possible, and, where necessary, other directly related provisions.
2021/02/05
Committee: EMPL
Amendment 99 #
Proposal for a directive
Article 1 – point -1 ai (new)
Directive 2004/37/EC
Article 17 – paragraph 1
(-1 ai) In Article 17, paragraph 1 is replaced by the following: "The Commission is empowered to adopt delegated acts in accordance with Article 17a to make strictly technical amendments to Annex II, in order to take account of technical progress, changes in international regulations or specifications and new findings with regard to carcinogens or, mutagens. or reprotoxic substances.”
2021/02/05
Committee: EMPL
Amendment 100 #
Proposal for a directive
Article 1 – point -1 aj (new)
Directive 2004/37/EC
Article 18a – paragraph 4 a (new)
(-1 aj) In Article 18a, the following paragraph is added: “No later than 1 December 2022, the Commission shall, taking into account the latest developments in scientific knowledge, the opinion of RAC and after appropriate consultation of relevant stakeholders, prepare Union guidelines on how the implementation of the limit values referred to in Article 5(4) should be adapted in the case of exposure to a combination of substances. Those guidelines shall be published on the website of the EU-OSHA and be disseminated in all Member States.”
2021/02/05
Committee: EMPL
Amendment 102 #
Proposal for a directive
Article 1 – point -1 al (new)
Directive 2004/37/EC
Article 18a – paragraph 4 a (new)
(-1al) In Article 18a, the following paragraph is added: “No later than 1 January 2028, the Commission shall, taking into account the RAC opinion of 2018 and the latest developments in scientific knowledge, start evaluating the feasibility of a further reduction of the limit value for benzene. No later than 1 January 2030, the Commission shall propose, where appropriate, necessary amendments and modifications related to that substance.”
2021/02/05
Committee: EMPL
Amendment 104 #
Proposal for a directive
Article 1 – point -1an (new)
Directive 2004/37/EC
Article 18a – paragraph 4 a (new)
(-1an) In Article 18a, the following paragraph is added: “No later than 1 March 2022, the Commission shall, taking into account the latest developments in scientific knowledge, and after appropriate consultation of relevant stakeholders, in particular health practitioners and health professionals, develop a definition of Hazardous Medicinal Products and establish the list of substances covered by the related entry in Annex I. The Commission shall review that list every two years. No later than 1 December 2022, the Commission shall, after the appropriate consultation of relevant stakeholders, prepare Union guidelines and standards of practice for the preparation, administration, and disposal of Hazardous Medicinal Products. Those guidelines and standards shall be published on the website of the European Agency for Safety and Health at Work (EU-OSHA) and shall be disseminated in all Member States. The consultations undertaken to develop the definition, list, guidelines and standards shall be transparent. The declarations of interests of stakeholders and experts shall be made public in a timely manner.”
2021/02/05
Committee: EMPL
Amendment 105 #
Proposal for a directive
Article 1 – point -1ao (new)
Directive 2004/37/EC
Article 18a – paragraph 4 a (new)
(-1ao) In Article 18 a, the following paragraph is inserted after the second paragraph: “No later than 1 June 2022, the Commission shall, taking into account the existing methodology to set limit values for carcinogens in some Member States and the opinion of the ACSH, define the upper and lower risk levels referred to in Article 2. No later than 1 December 2022, the Commission shall, after appropriate consultation of relevant stakeholders, prepare Union guidelines on the methodology establishing risk-based limit values under this Directive. Those guidelines shall be published on the website of the (EU-OSHA) and be disseminated in all Member States.”
2021/02/05
Committee: EMPL
Amendment 106 #
Proposal for a directive
Article 1 – point -1 ap (new)
Directive 2004/37/EC
Annex I – point 8 a (new)
(-1 ap) In Annex I the following point is added: “8a. Work involving exposure to Hazardous Medicinal Products as defined by the process outlined in article 18a and, meeting the criteria for classification as carcinogenic, mutagenic and/or toxic for reproduction category 1A or 1B set out in Annex I to Regulation (EC) No 1272/2008 of the European Parliament and of the Council.”
2021/02/05
Committee: EMPL
Amendment 107 #
Proposal for a directive
Article 1 – point -1 aq (new)
Directive 2004/37/EC
Annex II – point 1
(-1aq) In Annex II, point 1 is replaced by the following: “1. The doctor and/or authority responsible for the health surveillance of workers exposed to carcinogens or, mutagens or reprotoxic substances must be familiar with the exposure conditions or circumstances of each worker.
2021/02/05
Committee: EMPL